Does life expectancy of patients with hepatocellular carcinoma only depend on the upfront treatment?

被引：0
|
作者：
Fuks, David [1 ]
Marchese, Ugo
机构：
[1] Hop Cochin, Dept Hepatopancreat Biliary & Endocrine Surg, Assistance Publ Hop Paris, F-75014 Paris, France
来源：
DIAGNOSTIC AND INTERVENTIONAL IMAGING | 2023年 / 104卷 / 04期
关键词：
Chemoembolization; Hepatocellular carcinoma; Long-term prognosis; Radiofrequency ablation; Survival rate;
D O I：
10.1016/j.diii.2023.01.004
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：165 / 166
页数：2
相关论文
共 50 条
  • [1] Life expectancy of patients with hepatocellular carcinoma according to the upfront treatment: A nationwide analysis
    Cassinotto, Christophe
    Durand, Quentin
    Panaro, Fabrizio
    Assenat, Eric
    Dohan, Anthony
    Malafaye, Nicolas
    Guiu, Boris
    Molinari, Nicolas
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2023, 104 (04) : 192 - 199
  • [2] Does the life expectancy of elderly CLL patients receiving upfront targeted agents approach the life expectancy of the general population?
    Molica, Stefano
    Shanafelt, Tait
    Allsup, David
    Giannarelli, Diana
    LEUKEMIA & LYMPHOMA, 2023, 64 : S11 - S13
  • [3] Mortality Evaluation and Life Expectancy Prediction of Patients with Hepatocellular Carcinoma with Data Mining
    Liu, Che-Yu
    Cheng, Chen-Yang
    Yang, Szu-Ying
    Chai, Jyh-Wen
    Chen, Wei-Hao
    Chang, Pi-Yi
    HEALTHCARE, 2023, 11 (06)
  • [4] LIFE EXPECTANCY OF PATIENTS WITH INOPERABLE CARCINOMA
    VONELMEN.H
    ZEITSCHRIFT FUR KREBSFORSCHUNG, 1968, 71 (04): : 289 - &
  • [5] DOES TREATMENT OF ACROMEGALY AFFECT LIFE EXPECTANCY
    BATES, AS
    VANTHOFF, W
    JONES, JM
    CLAYTON, RN
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (01): : 1 - 5
  • [6] Life Expectancy After Liver Transplantation for Hepatocellular Carcinoma With Cirrhosis
    Kwak, Ji Hun
    Shavelle, Robert
    Brooks, Jordan
    PROGRESS IN TRANSPLANTATION, 2021, 31 (01) : 62 - 71
  • [7] Does delayed treatment affect the survival of patients with hepatocellular carcinoma?
    Liao, Ying-Yang
    Ou, Jie
    Luo, Cheng-Piao
    Peng, Ning-Fu
    Zhong, Jian-Hong
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : E14 - E16
  • [8] Quality of life changes in patients undergoing treatment for hepatocellular carcinoma
    Chie, Wei-Chu
    Yu, Fang
    Li, Mengqian
    Baccaglini, Lorena
    Blazeby, Jane M.
    Hsiao, Chin-Fu
    Chiu, Herng-Chia
    Poon, Ronnie T.
    Mikoshiba, Naoko
    Al-Kadhimi, Gillian
    Heaton, Nigel
    Calara, Jozer
    Collins, Peter
    Caddick, Katharine
    Costantini, Anna
    Vilgrain, Valerie
    Chiang, Chieh
    QUALITY OF LIFE RESEARCH, 2015, 24 (10) : 2499 - 2506
  • [9] Quality of life changes in patients undergoing treatment for hepatocellular carcinoma
    Wei-Chu Chie
    Fang Yu
    Mengqian Li
    Lorena Baccaglini
    Jane M. Blazeby
    Chin-Fu Hsiao
    Herng-Chia Chiu
    Ronnie T. Poon
    Naoko Mikoshiba
    Gillian Al-Kadhimi
    Nigel Heaton
    Jozer Calara
    Peter Collins
    Katharine Caddick
    Anna Costantini
    Valerie Vilgrain
    Chieh Chiang
    Quality of Life Research, 2015, 24 : 2499 - 2506
  • [10] Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
    Petta, S.
    Cabibbo, G.
    Barbara, M.
    Attardo, S.
    Bucci, L.
    Farinati, F.
    Giannini, E. G.
    Tovoli, F.
    Ciccarese, F.
    Rapaccini, G. L.
    Di Marco, M.
    Caturelli, E.
    Zoli, M.
    Borzio, F.
    Sacco, R.
    Virdone, R.
    Marra, F.
    Felder, M.
    Morisco, F.
    Benvegnu, L.
    Gasbarrini, A.
    Svegliati-Baroni, G.
    Foschi, F. G.
    Olivani, A.
    Masotto, A.
    Nardone, G.
    Colecchia, A.
    Persico, M.
    Boccaccio, V.
    Craxi, A.
    Bruno, S.
    Trevisani, F.
    Camma, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (01) : 160 - 168
12345